Navigation Links
Ernst & Young LLP Bolsters Fraud Investigation & Dispute Services with New Hires and Promotions
Date:12/5/2012

New York, NY (PRWEB) December 05, 2012

Ernst & Young LLP today announced a number of new hires, promotions and leadership changes in its Fraud Investigation & Dispute Services (FIDS) practice. The firm’s investment in this area reflects significant growth in demand from clients and their external legal counsel, particularly in financial services, life sciences and the public sector.

“With regulatory enforcement at historic levels, and clients adopting more robust measures to proactively address fraud, bribery and corruption risk, we continue to make strategic investments in our people,” said Brian Loughman, FIDS Leader for Ernst & Young LLP. “Given that our clients are increasingly operating in higher risk, rapid growth markets, they are looking for practical insights that reflect on-the-ground experience. Our professionals are particularly adept at helping companies navigate these challenging markets, working closely with the global Ernst & Young FIDS network in some 60 countries.”

Partner SanDee Priser has rejoined the US firm, to be based in New Jersey, after more than three years in Germany and Russia leading investigative and technology teams.

Additionally, Chris Costa returns to New York after four years in the UK where he will continue to serve the global organization while helping further strengthen the US firm’s practice.

Matt Jadacki has joined as an executive director in the firm’s Washington, DC office to build out a Federal Emergency Management Agency (FEMA) claims practice that will complement the FIDS Insurance Claims Services’ existing offerings.

Beth Junell has joined as a partner in the firm’s Dallas, TX office to expand its fraud and investigations practice. She has 20 years’ experience advising clients in major investigations and related remediation and compliance efforts, as well as work on high-profile monitorships and compliance matters.

Promotions include Tom Pannell (Media & Entertainment) and Stephen Ross (Financial Services) to partner, Brian Browne (Real Estate & Construction) and Vincent Hom (Life Sciences) to executive director and Patrick O’Connor (FIDS Business Development Leader) to director; all in New York. In Chicago, Miles Ripley (Consumer Products & Industrial) and Heidi Stenberg (Forensic Technology & Discovery Services) have both been promoted to principal, and in Philadelphia, Karen Makara (Life Sciences) was promoted to executive director.

The FIDS practices of Ernst & Young in South America are also growing rapidly with Marlon Jabbur and Liudmila Riano promoted to principal in Sao Paulo, Brazil, and Bogota, Colombia, respectively. Additionally, partners Andrea Rey and Jhon Ruiz are taking FIDS area leadership roles in Ernst & Young in Buenos Aires, Argentina, and Caracas, Venezuela, respectively.

“We are seeing significant growth in the variety of Ernst & Young’s service offerings throughout the Americas and abroad,” Loughman added. “Our team of established and emerging leaders is now in a better position to meet the needs of existing and potential clients regardless of the industry or business challenge.”

Ernst & Young’s Fraud Investigation & Dispute Services
Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to achieve your company’s potential. Better management of fraud risk and compliance exposure is a critical business priority – no matter the industry sector. With more than 2,000 fraud investigation and dispute professionals around the world, we assemble the right multidisciplinary and culturally aligned team to work with you and your legal advisors. And we work to give you the benefit of our broad sector experience, our deep subject matter knowledge and the latest insights from our work worldwide. It’s how Ernst & Young makes a difference.

About Ernst & Young
Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 167,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit http://www.ey.com.

This news release is issued by Ernst & Young LLP, a member firm providing services to clients in the US.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10203126.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
2. R&D Systems Publishes 100,000 Product Detail Web Pages
3. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
4. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
5. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
6. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
7. Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee
8. Jaipal Reddy, Honble Minister of Science and Technology & Earth Sciences, Inaugurates the International Bioenergy Summit in Delhi
9. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
10. Centers for Medicare & Medicaid Services Win 2012 National Cybersecurity Innovation Award
11. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Vermillion, Inc. (NASDAQ: VRML ... today announced the formation of the Steering Committee for ... --> Pelvic masses can present physicians ... management. Once pregnancy is ruled out, pelvic masses may ... advanced endometriosis, benign ovarian tumors and gastrointestinal and urinary ...
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... ; Frankfurt Prime Standard: QIA) today announced the introduction ... for gene expression profiling, expanding QIAGEN,s portfolio of Sample ... enable researchers to select from over 20,000 human genes ... interactions between genes, cellular phenotypes and disease processes. ...
(Date:2/11/2016)...  Bioethics International, a not-for-profit organization focused on the ethics ... made accessible to patients around the world, today announced that ... publication of the Good Pharma Scorecard an ... as one of BMJ Open ,s ,Most Popular Articles, ... most frequently read. Ed Sucksmith , assistant editor ...
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling Solutions ... that provides biopharma companies the experience, expertise, operational ... deploy outsourced sales teams. Created in concert with ... both the strategic and tactical needs of its ... solutions through both personal and non-personal promotion. ...
Breaking Biology Technology:
(Date:2/11/2016)... Feb. 11, 2016  Vigilant Solutions announces today that its ... being used by Lee,s Summit Police ... location and arrest of a homicide suspect. ... covers around 65 square miles and is home to roughly ... has a single mobile license plate reader system and also ...
(Date:2/10/2016)... February 10, 2016 ... to 2016 iris recognition market report, combined ... is more widely accepted for border control. ... fingerprint and iris recognition technology in a ... avoid purchasing two individual biometrics devices. ...
(Date:2/9/2016)... AWRE ), a leading supplier of biometrics software and services, ... December 31, 2015.  --> --> ... an increase of 61% compared to $4.3 million in the same ... was $2.6 million compared to $0.2 million in the fourth quarter ... Higher revenue and operating income in the fourth quarter of this ...
Breaking Biology News(10 mins):